Structures by: Mintas M.
Total: 17
Dibenz[c,e]azepine
C17H19N
Acta Crystallographica Section C (1998) 54, 6 877-879
a=9.1680(10)Å b=9.313(3)Å c=16.590(9)Å
α=90.00° β=105.88(2)° γ=90.00°
7-hydroxy-3-methoxy-4-methyl-5,6,7,8-tetrahydropyrido[1,2-c]pyrimidin- 1(8aH)-one
C10H14N2O3
Acta Crystallographica Section C (2005) 61, 3 o158-o160
a=9.955(4)Å b=6.9722(12)Å c=14.673(4)Å
α=90.00° β=90.00° γ=90.00°
(E)-1-[4-(N-Phthalimido)-2-butenyl]uracil
C16H13N3O4
Crystal Growth & Design (2008) 8, 8 2975
a=10.1870(2)Å b=13.4049(3)Å c=10.6494(2)Å
α=90.00° β=92.792(2)° γ=90.00°
(E)-1-[4-(N-Phthalimido)-2-butenyl]-5-fluorouracil
C16H12FN3O4
Crystal Growth & Design (2008) 8, 8 2975
a=9.4250(4)Å b=9.7967(4)Å c=10.3001(3)Å
α=63.852(4)° β=68.655(3)° γ=63.734(4)°
(E)-1-[4-(N-Phthalimido)-2-butenyl]-5-(trifluoromethyl)uracil
C17H12F3N3O4
Crystal Growth & Design (2008) 8, 8 2975
a=27.2485(6)Å b=6.8993(2)Å c=18.0188(5)Å
α=90.00° β=96.858(2)° γ=90.00°
(Z)-1-[4-(N-Phthalimido)-2-butenyl]-5-fluorouracil
C16H12FN3O4
Crystal Growth & Design (2008) 8, 8 2975
a=9.8863(6)Å b=10.3331(6)Å c=16.5554(9)Å
α=77.454(5)° β=83.765(5)° γ=61.683(6)°
(Z)-1-(4'-benzamide-2'-butenyl)cytosine
C15H16N4O2
Crystal Growth & Design (2012) 12, 11 5262
a=8.7354(6)Å b=9.8973(6)Å c=32.784(3)Å
α=90° β=90° γ=90°
(Z)-1-(4'-benzamide-2'-butenyl)-5-fluorocytosine
C15H15FN4O2
Crystal Growth & Design (2012) 12, 11 5262
a=8.5569(6)Å b=10.0070(6)Å c=33.317(4)Å
α=90° β=90° γ=90°
(Z)-1-(4'-(4''-fluoro)benzamide-2'-butenyl)cytosine
C15H15FN4O2
Crystal Growth & Design (2012) 12, 11 5262
a=16.4507(9)Å b=8.7236(3)Å c=9.9629(4)Å
α=90° β=90.171(5)° γ=90°
(Z)-1-[4'-(4''-fluoro)benzamide-2'-butenyl]-5-fluorocytosine hemihydrate
2(C15H14F2N4O2),H2O
Crystal Growth & Design (2012) 12, 11 5262
a=14.4861(5)Å b=19.8854(7)Å c=21.2864(8)Å
α=90° β=90° γ=90°
(Z)-1-(4'-benzamide-2'-butenyl)uracil
C15H15N3O3
Crystal Growth & Design (2012) 12, 11 5262
a=16.2425(8)Å b=11.2706(5)Å c=15.9376(9)Å
α=90° β=100.630(5)° γ=90°
(Z)-1-(4'-benzamide-2'-butenyl)-5-fluorouracil
C15H14FN3O3
Crystal Growth & Design (2012) 12, 11 5262
a=16.9098(7)Å b=11.2132(4)Å c=15.4936(7)Å
α=90° β=100.660(5)° γ=90°
(Z)-1-(4'-benzamide-2'-butenyl)thymine
C16H17N3O3
Crystal Growth & Design (2012) 12, 11 5262
a=11.7837(13)Å b=10.9280(8)Å c=23.738(2)Å
α=90° β=100.754(10)° γ=90°
(Z)-1-[4'-(4''-fluoro)benzamide-2'-butenyl]thymine
C16H16FN3O3
Crystal Growth & Design (2012) 12, 11 5262
a=5.921(2)Å b=30.199(10)Å c=10.162(4)Å
α=90° β=119.67(2)° γ=90°
(Z)-4-chloro-2-butenylbenzamide
C11H12ClNO
Crystal Growth & Design (2012) 12, 11 5262
a=4.3098(4)Å b=25.4209(16)Å c=9.7322(5)Å
α=90° β=96.947(7)° γ=90°
C10H9N5
C10H9N5
Zeitschrift für Kristallographie - New Crystal Structures (2002) 217, 2 273-274
a=11.053(1)Å b=10.231(1)Å c=16.639(2)Å
α=90.00° β=91.009(7)° γ=90.00°
C18H23NO5
C18H23NO5
Zeitschrift für Kristallographie - New Crystal Structures (2001) 216, 4 595-596
a=5.183(1)Å b=16.381(3)Å c=10.650(2)Å
α=90.00° β=102.43(1)° γ=90.00°